Advertisement

Topics

Nascent Pharmaceuticals, Inc. Company Profile

11:02 EST 13th December 2018 | BioPortfolio

Nascent Pharmaceuticals, Inc. is a privately held company funded by individual and institutional investors.Nascent’s lead institutional investor is Advantage Capital Partners, a private equity firm. Since 1992 Advantage has raised more than $700 million in institutional capital and has invested in a wide variety of companies and real estate projects. The firm targets its investment activities in geographic areas that are underserved by venture capital.

Location

533 Airport Boulevard, Suite 400
Burlingame
California
94010
United States of America

Contact

Phone: 919-806-4569
Email: readingc@nascentpharma.com


News Articles [338 Associated News Articles listed on BioPortfolio]

Life of proteins: from nascent chain to degradation

Names to Watch Amid Biotech's Nascent Rally

Click to view a price quote on XBI.

Roche enters NASH race with deal to buy Jecure

Company joins Novartis, Pfizer and others in nascent market

Novartis and Pfizer to collaborate on NASH combinations

Big pharma giants target nascent multi-billion market

STAT Plus: As drug makers scramble over the biosimilar market, a company has reportedly decided to focus exclusively on the U.S., a nascent, but particularly large opportunity for pharmaceutical companies. https://buff.ly/2TUoBri 

STAT Plus: As drug makers scramble over the biosimilar market, a company has reportedly decided to focus exclusively on the U.S., a nascent, but particularly large opportunity for pharmaceutical compa...

Five technologies that could disrupt pharma manufacturing

Pharma production is âtoo conservativeâ and needs to âbe bolderâ in adopting nascent technologies, or be left behind by new models, suggested one MD.

STAT Plus: Boehringer Ingelheim abandons biosimilar sales outside the U.S.

As drug makers scramble over the biosimilar market, one company has reportedly decided to focus exclusively on the U.S., a nascent, but particularly large opportunity for pharmaceutical companies.

A molecular look at nascent HDL formation

(American Society for Biochemistry and Molecular Biology) Researchers at Boston University pin down a molecular interaction between an apolipoprotein and a lipid transporter that's key to reverse chol...

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [197 Associated PubMed Articles listed on BioPortfolio]

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective.

Chiral pharmaceuticals (CPs), including non-steroid anti-inflammatory drugs (NSAIDs), β-blockers and some herbicide and pesticides, are widely used in aquaculture, clinical treatment and many other f...

Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.

The removal efficiency of pharmaceuticals in wastewater treatment plants (WWTPs) is variable and some of these compounds pass these plants almost intact and others presenting a removal efficiency clos...

Pervasive Targeting of Nascent Transcripts by Hfq.

Hfq is an RNA chaperone and an important post-transcriptional regulator in bacteria. Using chromatin immunoprecipitation coupled with high-throughput DNA sequencing (ChIP-seq), we show that Hfq associ...

Effects of pharmaceuticals on microbial communities and activity of soil enzymes in mesocosm-scale constructed wetlands.

Cyperus alternifolius based mesocosm-scale constructed wetland was employed to remove pharmaceuticals. We investigated the microbial community composition using phosphor lipid fatty acids (PFLAs) anal...

Clinical Trials [231 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1347 Associated Companies listed on BioPortfolio]

Nascent Pharmaceuticals, Inc.

Nascent Pharmaceuticals, Inc. is a privately held company funded by individual and institutional investors.Nascent’s lead institutional investor is Advantage Capital Partners, a private equity firm....

Nascent Biotech, Inc.

Nascent Biotech, Inc is a clinical-stage biotech company engaged in the development of monoclonal antibodies to be used in the treatment of various cancers. Its products are not c...

Atlantic Technology Ventures Incorproated

Atlantic Technology Ventures, Inc. (OTC: ATLC.OB), formerly known as Atlantic Pharmaceuticals, Inc., is a technology incubator engaged in developing and commercializing a diverse portfolio of patented...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Nascent Biotech Inc.

NBI is a biotechnology company developing human Monoclonal Antibodies (mAb’s) for immunotherapy of cancer. Its lead therapeutic candidate, Pritumumab, was the first human ant...

More Information about "Nascent Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Nascent Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Nascent Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Nascent Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Nascent Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Nascent Pharmaceuticals, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record